Author: Patelli, G.; Paganoni, S.; Besana, F.; Ronzoni, M.; Manini, S.; Remuzzi, A.
Title: Detection of lung hypoperfusion in Covid-19 patients during recovery by digital imaging quantification Cord-id: sjv78l0y Document date: 2020_6_3
ID: sjv78l0y
Snippet: Purpose. A large number of patients affected by the SARS-Cov-2 virus worldwide undergo recovery of symptoms in about one month. Among these patients, the healing process is still under observation, with some patients in need of careful clinical monitoring. While the radiological findings have been shown to regress almost completely, little knowledge is available at the moment about other complications in the lung and in other organs. We then investigated the lung perfusion conditions in patients
Document: Purpose. A large number of patients affected by the SARS-Cov-2 virus worldwide undergo recovery of symptoms in about one month. Among these patients, the healing process is still under observation, with some patients in need of careful clinical monitoring. While the radiological findings have been shown to regress almost completely, little knowledge is available at the moment about other complications in the lung and in other organs. We then investigated the lung perfusion conditions in patients affected by COVID- 19 during recovery. Method. We retrospectively studied 20 patients, from 14 to 60 days after resolution of the COVID-19 symptoms, using chest CT. In a subgroup of 5 patients contrasted CT was used. Beside normal radiological evaluation of lung tissue, perfusion conditions were evaluated by digital image processing in the lung volume automatically segmented. Results. Pulmonary lung evaluation showed that COVID-19 pneumonia almost completely regressed, with mild focal areas affected by fibrous stripes. In patients that reported dyspnea, lung CT showed complete resolution of interstitial changes. Quantification of lung perfusion condition by contrasted CT, showed that dyspnea in 3 patients was associated with areas of hypoperfusion, while in 2 patients not reporting dyspnea perfusion conditions were comparable to normal controls. Conclusions. Although we obtained preliminary data, this is the first report on quantitative evaluation of hypoperfused lung tissue detected in recovering COVID-19 patients. These results suggest the need to further investigate these patients and to redefine the role of CT evaluation for diagnostic purposes as well as for evaluation of potential treatments.
Search related documents:
Co phrase search for related documents- activation inflammatory cytokine and lung damage: 1
- acute lung damage and lung blood: 1
- acute lung damage and lung blood perfusion: 1
- acute lung damage and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- acute lung damage and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute lung damage and lung function affect: 1
- acute lung damage and lung parenchyma: 1
- acute lung damage and lung perfusion: 1
- acute lung damage and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute lung damage and lung tissue damage: 1, 2, 3, 4, 5, 6, 7
- acute phase and lung blood: 1, 2, 3, 4, 5, 6
- acute phase and lung complication: 1, 2
- acute phase and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- acute phase and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- acute phase and lung immune cell accumulation: 1
- acute phase and lung parenchyma: 1, 2, 3, 4
- acute phase and lung perfusion: 1, 2, 3, 4
- acute phase and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- acute phase and lung tissue damage: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date